+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group



Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group



Progress in Clinical and Biological Research 337: 301-307




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041862846

Download citation: RISBibTeXText

PMID: 2352989


Related references

Treatment protocols of the lupus nephritis collaborative study of plasmapheresis in severe lupus nephritis. Rock, G (Ed ) Progress in Clinical And Biological Research, Vol 337 Apheresis; 2nd International Congress Of The World Apheresis Association, Ottawa, Ontario, Canada, May 18-20, 1988 Li+592p Wiley-Liss: New York, New York, Usa: Chichester, England, Uk Illus 301-308, 1990

Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Annals of Internal Medicine 114(11): 924-929, 1991

A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. New England Journal of Medicine 326(21): 1373-1379, 1992

Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. American Journal of Kidney Diseases 35(5): 904-914, 2000

Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. Lupus Nephritis Collaborative Study Group. American Journal of Kidney Diseases 21(4): 374-377, 1993

Plasmapheresis therapy is ineffective in SLE. Lupus Nephritis Collaborative Study Group. Journal of Clinical Apheresis 7(3): 153, 1992

Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group. Journal of the American Society of Nephrology 7(2): 299-305, 1996

Lupus nephritis: induction therapy in severe lupus nephritis--should MMF be considered the drug of choice?. Clinical Journal of the American Society of Nephrology 8(1): 147-153, 2013

Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis. Lupus 22(6): 574-582, 2013

Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study. Controlled Clinical Trials 13(1): 62-79, 1992

Clinical guideline for the treatment of lupus nephritis and single-centre results of mycofenolate mofetil among patients with lupus nephritis in the National Institute of Rheumatology and Physiotherapy, Budapest. Orvosi Hetilap 157(35): 1385-1393, 2016

Future prospects in the treatment of lupus nephritis: proliferative lupus nephritis. Future Rheumatology 2(3): 297-303, 2007

Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. American Journal of Kidney Diseases 18(6): 678-685, 1991

Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Annals of the Rheumatic Diseases 68(2): 234-237, 2009

OP0045Efficacy of the Euro-Lupus Nephritis Regimen Combined with Abatacept VS Placebo in A North American Lupus Nephritis Population. Annals of the Rheumatic Diseases 73(Suppl 2): 77.3-78, 2014